OPKO Health, Inc. (OPK) stock
OPKNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/305% above fair value
$1.62+0.00 (0.00%)
Close on Nov 17, 2026Market cap $1.21BP/E –Yield –
OPKO Health total assets
Total assets on the balance sheet at the end of each period.
OPKO Health's total assets was $1.83B at Jun 30, 2026. For fiscal 2025 it was $1.93B, down 12.2% from the year before. Over ten years it grew -3.6% a year on average. The highest annual figure on record is $2.80B in fiscal 2015.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.93B | -12.2% |
| FY2024 | Dec 31, 2024 | $2.20B | +9.4% |
| FY2023 | Dec 31, 2023 | $2.01B | -7.2% |
| FY2022 | Dec 31, 2022 | $2.17B | -9.7% |
| FY2021 | Dec 31, 2021 | $2.40B | -3.0% |
| FY2020 | Dec 31, 2020 | $2.47B | +7.1% |
| FY2019 | Dec 31, 2019 | $2.31B | -5.8% |
| FY2018 | Dec 31, 2018 | $2.45B | -5.4% |
| FY2017 | Dec 31, 2017 | $2.59B | -6.4% |
| FY2016 | Dec 31, 2016 | $2.77B | -1.2% |
| FY2015 | Dec 31, 2015 | $2.80B | +120.8% |
| FY2014 | Dec 31, 2014 | $1.27B | -8.9% |
| FY2013 | Dec 31, 2013 | $1.39B | +380.1% |
| FY2012 | Dec 31, 2012 | $289.83M | +26.3% |
| FY2011 | Dec 31, 2011 | $229.49M | +194.8% |
| FY2010 | Dec 31, 2010 | $77.85M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.83B | -7.3% |
| Q1 FY2026 | Mar 31, 2026 | $1.86B | -12.8% |
| Q4 FY2025 | Dec 31, 2025 | $1.93B | -12.2% |
| Q3 FY2025 | Sep 30, 2025 | $2.00B | -11.6% |
| Q2 FY2025 | Jun 30, 2025 | $1.97B | -0.3% |
| Q1 FY2025 | Mar 31, 2025 | $2.13B | +7.8% |
| Q4 FY2024 | Dec 31, 2024 | $2.20B | +9.4% |
| Q3 FY2024 | Sep 30, 2024 | $2.26B | +9.7% |
| Q2 FY2024 | Jun 30, 2024 | $1.98B | -8.3% |
| Q1 FY2024 | Mar 31, 2024 | $1.97B | -9.0% |
| Q4 FY2023 | Dec 31, 2023 | $2.01B | -7.2% |
| Q3 FY2023 | Sep 30, 2023 | $2.06B | -7.6% |
| Q2 FY2023 | Jun 30, 2023 | $2.16B | -8.9% |
| Q1 FY2023 | Mar 31, 2023 | $2.17B | -5.9% |
| Q4 FY2022 | Dec 31, 2022 | $2.17B | -9.7% |
| Q3 FY2022 | Sep 30, 2022 | $2.22B | -8.0% |
| Q2 FY2022 | Jun 30, 2022 | $2.37B | -2.1% |
| Q1 FY2022 | Mar 31, 2022 | $2.31B | -8.4% |
| Q4 FY2021 | Dec 31, 2021 | $2.40B | -3.0% |
| Q3 FY2021 | Sep 30, 2021 | $2.42B | +2.0% |
| Q2 FY2021 | Jun 30, 2021 | $2.42B | +4.2% |
| Q1 FY2021 | Mar 31, 2021 | $2.52B | +12.9% |
| Q4 FY2020 | Dec 31, 2020 | $2.47B | +7.1% |
| Q3 FY2020 | Sep 30, 2020 | $2.37B | +0.1% |
| Q2 FY2020 | Jun 30, 2020 | $2.32B | -5.4% |
| Q1 FY2020 | Mar 31, 2020 | $2.23B | -13.3% |
| Q4 FY2019 | Dec 31, 2019 | $2.31B | -5.8% |
| Q3 FY2019 | Sep 30, 2019 | $2.37B | -4.5% |
| Q2 FY2019 | Jun 30, 2019 | $2.46B | -3.0% |
| Q1 FY2019 | Mar 31, 2019 | $2.58B | -0.1% |
| Q4 FY2018 | Dec 31, 2018 | $2.45B | -5.4% |
| Q3 FY2018 | Sep 30, 2018 | $2.48B | -8.9% |
| Q2 FY2018 | Jun 30, 2018 | $2.53B | -8.6% |
| Q1 FY2018 | Mar 31, 2018 | $2.58B | -6.6% |
| Q4 FY2017 | Dec 31, 2017 | $2.59B | -6.4% |
| Q3 FY2017 | Sep 30, 2017 | $2.72B | -2.8% |
| Q2 FY2017 | Jun 30, 2017 | $2.77B | – |
| Q1 FY2017 | Mar 31, 2017 | $2.76B | – |
| Q4 FY2016 | Dec 31, 2016 | $2.77B | – |
| Q3 FY2016 | Sep 30, 2016 | $2.80B | – |
See a number that looks wrong?